OncoDiag Taking Aim at Broader Adoption of Molecular Multiplex Test for Bladder Cancer Recurrence Genomeweb, 16 Apr 2021 NEW YORK ─ French diagnostic test developer OncoDiag has commenced commercialization of its first test, a multiplex, real-time…